Early Registration Deadline Approaching for Latin America Conference
During the IASLC’s 2023 Latin America Conference on Lung Cancer (LALCA), an international slate of speakers will gather to discuss the science, advances in the treatment, and prevention of lung cancer and thoracic malignancies in Latin America and around the world.
The conference will take place January 25–27 at the Radisson Hotel Montevideo Victoria Plaza in beautiful Montevideo, Uruguay. Simultaneous translation in English and Spanish will be provided for all sessions. Early registration ends November 18.
Clinicians, researchers, patients, caregivers, and advocates are encouraged to attend LALCA 23. Not only will attendees meet international experts in the field and participate in discussions on the latest advances in prevention, therapeutic development, and research in thoracic malignancies, but they will also learn how Latin American countries can play a fundamental role in reducing the burden of lung cancer.
The conference will once again feature a Cancer Control Program and Tobacco Forum, which will take place Wednesday, January 25. The popular Round Table Discussion session also returns for LACLC 23. This event provides delegates an opportunity for in-depth discussions with international leaders and local experts on specific topics.
Learn more and register at lalca2023.iaslc.org.
Don’t Miss the 2022 Asia Conference on Lung Cancer
IASLC’s 2022 Asia Conference on Lung Cancer begins October 27, in Nara, Japan, and it’s not too late to register. Whether you’re in Nara and can attend in person or around the globe and attending virtually, ACLC offers wide-ranging, multidisciplinary content including keynote lectures by such distinguished professionals as Drs. Yi-Long Wu, Yu-Ju Chen, Ross Soo, Hirokazu Matsushita, Solange Peters, Josh Lin, Caicun Zhou, Tetsuya Mitsudomi, Heather Wakelee, and Masahiro Tsuboi, as well as Professors Koji Tamada and Paul Van Schil.
Sessions will highlight treatments in non-small cell lung cancer (NSCLC) at various stages; diagnosis, imaging, and bronchoscopy; small-cell lung cancer (SCLC); mesothelioma; thymoma; palliative and supportive care; risk reduction and early detection; and more.
With ACLC’s hybrid platform, attendees will have access to all recorded sessions within 24 hours of when they are presented live. In addition, attendees can access posters and connect with delegates, speakers and sponsors. Visit aclc2022.iaslc.org for program details and to register today.
Abstract Submissions Open Soon for Targeted Therapies Meeting
Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies at the 2023 Targeted Therapies of Lung Cancer Meeting (TTLC) February 22–25 in Santa Monica, California.
TTLC presenters will summarize the data on relevant targets for new therapies and share data on preclinical and early clinical data for each of the drugs directed against these targets. Abstract submission opens November 1, 2022, and closes December 2, 2022. For more details, including abstract submission guidelines, visit ttlc2023.iaslc.org.